Cardiometabolic Disorders

Top Story

Positive CV results reported for dapagliflozin

September 24, 2018
In the Journals

Patients with undiagnosed hypertension often have no history of CVD, diabetes

September 24, 2018
Patients with undiagnosed hypertension typically had no other CVD or diabetes, according to findings recently published in Family Practice. “A primary care…
In the Journals Plus

Early signs of fatty liver, subclinical heart disease found in children with metabolically healthy obesity

September 20, 2018
Despite a lack of conventional cardiometabolic risk factors, children with so-called metabolically healthy obesity have a higher prevalence of hepatic steatosis and left…
In the Journals Plus

Metformin ineffective for long-term metabolic improvements in teen obesity

September 19, 2018
Adolescents with obesity assigned to long-term metformin therapy experienced initial improvements in BMI and insulin resistance that were not sustained after 3 years…
More Headlines »

Understanding and Managing a Complex Dual Dilemma: Diabetes and Dyslipidemia

This activity is supported by an educational grant from Amgen.

Patients with type 2 diabetes have increased cardiovascular risk. Inhibitors of proprotein convertase subtilisin/kexin…
More »
Meeting News

In type 2 diabetes, consider disease burden when managing blood pressure

May 18, 2018
More »
Resource Centers
American Association of Diabetes Educators Annual Meeting

American Association of Diabetes Educators Annual Meeting


Practical Lipidology® (Volume 4): Focus on: LDL Reduction and PCSK9 Inhibition

This activity is supported by an educational grant from Amgen, Inc.

The reduction of low-density lipoprotein cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »